Search research articles
Contact Us
Filters
Showing results (111-120 of 116) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 116 results.
Journal of the National Cancer Institute
|
November 11, 2017
The Future of Radiobiology
David G Kirsch, Max Diehn, Aparna H Kesarwala, et al.
Haematologica
|
May 17, 2020
Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas
Jakub Svoboda, Steven M Bair, Daniel J Landsburg, et al.
Nature
|
March 11, 2015
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Christina Twyman-Saint Victor, Andrew J Rech, Amit Maity, et al.
Cancer Research
|
July 29, 2021
FLASH Proton Radiotherapy Spares Normal Epithelial and Mesenchymal Tissues While Preserving Sarcoma Response
Anastasia Velalopoulou, Ilias V Karagounis, Gwendolyn M Cramer, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 30, 2023
Framework for Quality Assurance of Ultrahigh Dose Rate Clinical Trials Investigating FLASH Effects and Current Technology Gaps
Wei Zou, Rongxiao Zhang, Emil Schüler, et al.
Blood Advances
|
April 9, 2025
Bridging Radiotherapy Prior to Chimeric Antigen Receptor T-Cells for B-Cell Lymphomas: An ILROG Multicenter Study
Nikhil Yegya-Raman, John P Plastaras, Christopher M Wright, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 116) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 116 results.
Journal of the National Cancer Institute
|
November 11, 2017
The Future of Radiobiology
David G Kirsch, Max Diehn, Aparna H Kesarwala, et al.
Haematologica
|
May 17, 2020
Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas
Jakub Svoboda, Steven M Bair, Daniel J Landsburg, et al.
Nature
|
March 11, 2015
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Christina Twyman-Saint Victor, Andrew J Rech, Amit Maity, et al.
Cancer Research
|
July 29, 2021
FLASH Proton Radiotherapy Spares Normal Epithelial and Mesenchymal Tissues While Preserving Sarcoma Response
Anastasia Velalopoulou, Ilias V Karagounis, Gwendolyn M Cramer, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 30, 2023
Framework for Quality Assurance of Ultrahigh Dose Rate Clinical Trials Investigating FLASH Effects and Current Technology Gaps
Wei Zou, Rongxiao Zhang, Emil Schüler, et al.
Blood Advances
|
April 9, 2025
Bridging Radiotherapy Prior to Chimeric Antigen Receptor T-Cells for B-Cell Lymphomas: An ILROG Multicenter Study
Nikhil Yegya-Raman, John P Plastaras, Christopher M Wright, et al.
Page
of 12